Cdk5 protein inhibition and Aβ42 increase BACE1 protein level in primary neurons by a post-transcriptional mechanism: implications of CDK5 as a therapeutic target for Alzheimer disease (Q35801936)

From Wikidata
Jump to navigation Jump to search
scientific article published on 5 January 2012
edit
Language Label Description Also known as
English
Cdk5 protein inhibition and Aβ42 increase BACE1 protein level in primary neurons by a post-transcriptional mechanism: implications of CDK5 as a therapeutic target for Alzheimer disease
scientific article published on 5 January 2012

    Statements

    Cdk5 protein inhibition and Aβ42 increase BACE1 protein level in primary neurons by a post-transcriptional mechanism: implications of CDK5 as a therapeutic target for Alzheimer disease (English)
    Katherine R Sadleir
    Robert Vassar
    5 January 2012
    287
    7224-7235

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit